NCT05371288WithdrawnEarly phase 1
The Role of Glutathione Deficiency and MSIDS Variables in Long COVID-19
Source: ClinicalTrials.gov · Last updated 5 Nov 2024
Reason given: No longer studying long COVID
Brief summary (registry, in English)
The purpose of this research study is to assess if glutathione, along with NAC (N-acetyl cysteine) and Alpha lipoic acid (ALA), can help reverse some of the COVID long-haul symptoms.Subjects will be randomized in to one of two groups. Depending on the group they are randomized in to, subjects will be taking either a combination of NAC, Alamax CR, and liposomal GSH or the same three nutritional supplements with a multivitamin and magnesium. Regardless of the group, subjects will be asked questions to assess their COVID symptoms, physical and mental health status. They will also be asked to take blood samples.
- Status (registry)
- Withdrawn
- Phase (registry)
- Early phase 1
- Study type
- Interventional
- Enrollment
- 0 (actual)
- First submitted
- 8 Apr 2022
- Start date
- Jun 2025
- Primary completion date
- Sept 2025
- Lead sponsor
- University of California, Irvine
- Diseases
- Long COVID and ME/CFS
- NCT number
- NCT05371288
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of a severe sulfa sensitivity (i.e., anaphylaxis, Stevens Johnson Syndrome), allergy to meat products and/or gelatin (alpha gal allergy) and/or a history of an allergic or adverse reaction to NAC, alpha lipoic acid and/or GSH.
Who the study is looking for
- Patients with positive COVID testing (AB, RT PCR) and mild-severe symptoms based on COVID symptom list
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of California Irvine Medical Center | Orange | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.